Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Lairson

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 21, 2015
Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian CancerInsiya B Poonawalla, David R Lairson, Wenyaw Chan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 29, 2015
Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With ChemotherapyInsiya B Poonawalla, Linda B Piller, David R Lairson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older WomenDavid R Lairson, Rohan C Parikh, Janice N Cormier, et al.
Journal of the American Medical Informatics Association : JAMIA|June 27, 2006
Estimating development cost for a tailored interactive computer program to enhance colorectal cancer screening complianceDavid R Lairson, Yu-Chia Chang, Judith L Bettencourt, et al.
Evaluation and Program Planning|May 15, 2013
The cost of implementing a 2-1-1 call center-based cancer control navigator programDavid R Lairson, Jinhai Huo, Katharine A Ball Ricks, et al.
Pharmacoeconomics|June 13, 2014
Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancerDavid R Lairson, Rohan C Parikh, Janice N Cormier, et al.
Cancer Epidemiology|December 12, 2018
Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areasShuangshuang Fu, Michael Wang, Ruosha Li, et al.
Pharmacoeconomics|July 19, 2018
Medical Care Costs Associated with Genital Warts for Commercially Insured US PatientsKristina R Dahlstrom, Shuangshuang Fu, Wenyaw Chan, et al.
Statistics in Medicine|July 2, 2024
Latent classification model for censored longitudinal binary outcomeJacky C Kuo, Wenyaw Chan, Luis Leon-Novelo, et al.
Pharmacoeconomics|June 15, 2015
Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic ReviewInsiya B Poonawalla, Rohan C Parikh, Xianglin L Du, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 21, 2015
Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian CancerInsiya B Poonawalla, David R Lairson, Wenyaw Chan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 29, 2015
Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With ChemotherapyInsiya B Poonawalla, Linda B Piller, David R Lairson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older WomenDavid R Lairson, Rohan C Parikh, Janice N Cormier, et al.
Journal of the American Medical Informatics Association : JAMIA|June 27, 2006
Estimating development cost for a tailored interactive computer program to enhance colorectal cancer screening complianceDavid R Lairson, Yu-Chia Chang, Judith L Bettencourt, et al.
Evaluation and Program Planning|May 15, 2013
The cost of implementing a 2-1-1 call center-based cancer control navigator programDavid R Lairson, Jinhai Huo, Katharine A Ball Ricks, et al.
Pharmacoeconomics|June 13, 2014
Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancerDavid R Lairson, Rohan C Parikh, Janice N Cormier, et al.
Cancer Epidemiology|December 12, 2018
Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areasShuangshuang Fu, Michael Wang, Ruosha Li, et al.
Pharmacoeconomics|July 19, 2018
Medical Care Costs Associated with Genital Warts for Commercially Insured US PatientsKristina R Dahlstrom, Shuangshuang Fu, Wenyaw Chan, et al.
Statistics in Medicine|July 2, 2024
Latent classification model for censored longitudinal binary outcomeJacky C Kuo, Wenyaw Chan, Luis Leon-Novelo, et al.
Pharmacoeconomics|June 15, 2015
Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic ReviewInsiya B Poonawalla, Rohan C Parikh, Xianglin L Du, et al.
Pageof 12